Ovarian Cancer Grants
Tina’s Wish - Dedicated to the early detection of ovarian cancer.

Enter your keyword

How to Apply

Tina’s Wish 2026/27 Grants

Applications for the 2026-27 Rising Star and Team Science Grants are now available, please see below for information on how to apply. Please Click Here to learn more about the types of grants we fund and the 2024-25 Grantees.

To be added to our mailing list for future grant opportunities, please contact grants@tinaswish.org 

2026-27 Team Science Grant

The Honorable Tina Brozman Foundation (“Tina’s Wish”) is requesting Letters of Intent (LOI) for the Tina’s Wish Team Science awards for 2026-27. Tina’s Wish awards grants to researchers proposing new ideas and concepts specifically for the early detection or interception of ovarian cancer.

The 2026-27 Team Science Grants are now funded at $250,000/year for two (2) years, total grant award: $500,000.

Timeline

  1. LOI application deadline: Monday, March 31st, 2025 at 12pm ET.
  2. All applicants will be notified of the LOI outcome around May 5, 2025.
  3. Full proposal submission deadline: Monday, June 30, 2025 at 12pm ET.
  4. All applications will be notified of the Proposal outcome in early November 2025.
  5. Start of Year 1 funding: January 2026.

Eligibility and Selection Criteria (applicants must meet ALL the criteria listed; additional details in the above pdf)

  1. Applicants must be working in a school of medicine or public health or a recognized non-profit scientific research facility in the United States.
  2. Applicants must have attained the faculty position of Assistant Professor or higher (or equivalent). If at the Instructor level, independent lab leads are eligible; (if lab is embedded within a more senior/established lab, please apply for the Rising Star Grant).
  3. Projects must be innovative and focused on early detection or interception of ovarian cancer. For this funding call, Interception refers to disruption of the oncogenic process during the precursor or precancer state. Research on primary prevention of cancer before the oncogenic process begins is not eligible.
  4. Projects must exemplify/embody collaborative science: the collaboration between/among two or more researchers with different scientific expertise; the grantees can reside within the same institution or across institutions.
  5. The research for which support is requested should not be currently funded.

2026-27 Rising Star Grant

The Honorable Tina Brozman Foundation (“Tina’s Wish”) is requesting Proposals for the Tina’s Wish Rising Star Grants for 2026-27.  Tina’s Wish is committed to supporting early career researchers who bring fresh approaches to the study of the early detection or interception of ovarian cancer.  The goal is to assist and support promising researchers in the ovarian cancer field and to encourage them to take risks and develop innovative projects.

The 2026-27 Rising Star Grants are now funded at $100,000/year for two (2) years, total grant award: $200,000.

Timeline

  1. Full Proposal Application deadline: Monday, June 2nd, 12pm ET.
  2. Announcement of the 2026-27 Rising Star Grant (RSG) will be made by November 2025.
  3. Written critiques will not be provided to any applicants.
  4. Funding will commence on or around January 1, 2026.

Eligibility and Selection Criteria (applicants must meet ALL the criteria; additional details in the above pdf)

  1. Applicants must be working in a school of medicine or public health, or a recognized non-profit scientific research facility in the United States.
  2. Applicants should hold a PhD, MD, or MD, PhD degree.
    1. PhD applicants must be in a postdoctoral position or within three (3) years of their first faculty appointment  (a non-tenured level position) when the grant begins in January 2026.  PhD applicants at the instructor level are eligible to apply if their lab is embedded in a more senior/established lab; PhD applicants at the Instructor level who have an independent lab should review the Team Science Grant (TSG) opportunity.
    2. MD or MD, PhD applicants must be at the instructor or assistant professor level (or a similar faculty position) and within three years of starting their first faculty appointment at the time of the estimated award date (January 2026).  Note:  Clinical or research fellows with dedicated research time for the full two years of the Rising Star Grant funding period (January 2026-December 2027) will also be eligible. Fellows should include a letter of institutional commitment from one’s department chair of at least 75% research time for the Rising Star Grant funding period with their application; dedicated research time can be contingent about receipt of the Rising Star grant .
  3. Applicants must have a committed mentor to support the applicant throughout the grant period.  One’s mentor does not need to be at the same institution as the applicant, provided that the mentor is committed to a meaningful and productive relationship throughout the grant period.
  4. Projects must be innovative and focused on early detection or interception of ovarian cancer. For this funding call, Interception refers to disruption of the oncogenic process during the precursor or precancer state. Research on primary prevention of cancer before the oncogenic process begins is not eligible.
  5. The research project for which support is requested should be innovative and not currently funded.
#1

deadliest gynecologic
cancer

80%

of women are diagnosed
at an advanced stage

27%

of women have a 5-year
survival rate after an
advanced stage diagnosis